197 related articles for article (PubMed ID: 24985891)
21. Effects of Acute and Chronic Treatments with Dopamine D
Thomsen M; Barrett AC; Butler P; Negus SS; Caine SB
J Pharmacol Exp Ther; 2017 Jul; 362(1):161-176. PubMed ID: 28473458
[TBL] [Abstract][Full Text] [Related]
22. Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors.
Piercey MF; Hyslop DK; Hoffmann WE
Brain Res; 1997 Jul; 762(1-2):19-28. PubMed ID: 9262154
[TBL] [Abstract][Full Text] [Related]
23. Double dissociation of the behavioural effects of R(+) 7-OH-DPAT infusions in the central and basolateral amygdala nuclei upon Pavlovian and instrumental conditioned appetitive behaviours.
Hitchcott PK; Phillips GD
Psychopharmacology (Berl); 1998 Dec; 140(4):458-69. PubMed ID: 9888622
[TBL] [Abstract][Full Text] [Related]
24. Dopamine D
Rodgers HM; Lim SA; Yow J; Dinkins ML; Patton R; Clemens S; Brewer KL
Pharmacol Biochem Behav; 2020 Jul; 194():172935. PubMed ID: 32335101
[TBL] [Abstract][Full Text] [Related]
25. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
[TBL] [Abstract][Full Text] [Related]
26. The motivation to obtain nicotine-conditioned reinforcers depends on nicotine dose.
Palmatier MI; Coddington SB; Liu X; Donny EC; Caggiula AR; Sved AF
Neuropharmacology; 2008 Dec; 55(8):1425-30. PubMed ID: 18809417
[TBL] [Abstract][Full Text] [Related]
27. Responding for conditioned reinforcement in C57BL/6 and CD-1 mice, and Sprague-Dawley rats: Effects of methylphenidate and amphetamine.
Browne JD; Soko AD; Fletcher PJ
Psychopharmacology (Berl); 2014 Dec; 231(23):4503-16. PubMed ID: 24804572
[TBL] [Abstract][Full Text] [Related]
28. Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans.
Newton TF; Haile CN; Mahoney JJ; Shah R; Verrico CD; De La Garza R; Kosten TR
Psychiatry Res; 2015 Nov; 230(1):44-9. PubMed ID: 26239766
[TBL] [Abstract][Full Text] [Related]
29. Pramipexole effects on startle gating in rats and normal men.
Swerdlow NR; Lelham SA; Sutherland Owens AN; Chang WL; Sassen SD; Talledo JA
Psychopharmacology (Berl); 2009 Sep; 205(4):689-98. PubMed ID: 19506839
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists.
Piercey MF; Hoffmann WE; Smith MW; Hyslop DK
Eur J Pharmacol; 1996 Sep; 312(1):35-44. PubMed ID: 8891576
[TBL] [Abstract][Full Text] [Related]
31. In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors.
Fenu S; Espa E; Pisanu A; Di Chiara G
Eur J Pharmacol; 2016 Oct; 788():183-191. PubMed ID: 27343381
[TBL] [Abstract][Full Text] [Related]
32. Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures.
Ling ZD; Robie HC; Tong CW; Carvey PM
J Pharmacol Exp Ther; 1999 Apr; 289(1):202-10. PubMed ID: 10087005
[TBL] [Abstract][Full Text] [Related]
33. Self-administration of remifentanil, an ultra-short acting opioid, under continuous and progressive-ratio schedules of reinforcement in rats.
Panlilio LV; Schindler CW
Psychopharmacology (Berl); 2000 May; 150(1):61-6. PubMed ID: 10867977
[TBL] [Abstract][Full Text] [Related]
34. The effects of nicotine exposure during Pavlovian conditioning in rats on several measures of incentive motivation for a conditioned stimulus paired with water.
Guy EG; Fletcher PJ
Psychopharmacology (Berl); 2014 Jun; 231(11):2261-71. PubMed ID: 24317443
[TBL] [Abstract][Full Text] [Related]
35. Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus.
Weissenborn R; Deroche V; Koob GF; Weiss F
Psychopharmacology (Berl); 1996 Aug; 126(4):311-22. PubMed ID: 8878347
[TBL] [Abstract][Full Text] [Related]
36. Pramipexole has astrocyte-mediated neuroprotective effects against lactacystin toxicity.
Imamura K; Takeshima T; Nakaso K; Ito S; Nakashima K
Neurosci Lett; 2008 Aug; 440(2):97-102. PubMed ID: 18555604
[TBL] [Abstract][Full Text] [Related]
37. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.
Siuciak JA; Fujiwara RA
Psychopharmacology (Berl); 2004 Sep; 175(2):163-9. PubMed ID: 14985923
[TBL] [Abstract][Full Text] [Related]
38. Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats.
Kitagawa K; Kitamura Y; Miyazaki T; Miyaoka J; Kawasaki H; Asanuma M; Sendo T; Gomita Y
Naunyn Schmiedebergs Arch Pharmacol; 2009 Jul; 380(1):59-66. PubMed ID: 19274453
[TBL] [Abstract][Full Text] [Related]
39. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors.
Svensson K; Carlsson A; Huff RM; Kling-Petersen T; Waters N
Eur J Pharmacol; 1994 Oct; 263(3):235-43. PubMed ID: 7843260
[TBL] [Abstract][Full Text] [Related]
40. Individual variation in the motivational and neurobiological effects of an opioid cue.
Yager LM; Pitchers KK; Flagel SB; Robinson TE
Neuropsychopharmacology; 2015 Mar; 40(5):1269-77. PubMed ID: 25425322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
